European Biotech Acquisition Corporation News - EBACU

Annual Report (10-k)

falseFY0001841258--12-31NL00-000000000000 0001841258 2021-01-08 2021-12-31 0001841258 2021-12-31 0001841258 2021-06-30 0001841258 2021-01-07...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act...

Current Report Filing (8-k)

0001841258 false 00-0000000 00000 NASDAQ NASDAQ NASDAQ true 0001841258 2021-11-22 2021-11-22 0001841258 us-gaap:CommonClassAMember...

Quarterly Report (10-q)

12754784falseQ30001841258--12-3100-000000000000 0001841258 2021-01-08 2021-09-30 0001841258 2021-07-01 2021-09-30 0001841258 2021-09-30...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION...

Quarterly Report (10-q)

falseQ20001841258--12-3100-000000000000 0001841258 2021-01-08 2021-06-30 0001841258 2021-04-01 2021-06-30 0001841258 2021-06-30 0001841258...

Quarterly Report (10-q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report

European Biotech Acquisition Corp. (the “Company”) today announced it received a notice on May 28, 2021 from the Nasdaq Stock Market LLC...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K...

European Biotech Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares & Warrants Commencing May 6,...

European Biotech Acquisition Corp. (the “Company”) announced today that, commencing May 6, 2021, holders of the units sold in the Company’s...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

European Biotech Acquisition Corporation (EBACU)

Professional-Grade Tools, for Individual Investors.

EBACU News

Annual Report (10-k)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Current Report Filing (8-k)

Quarterly Report (10-q)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Quarterly Report (10-q)

Quarterly Report (10-q)

European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report

Current Report Filing (8-k)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Initial Statement of Beneficial Ownership (3)

Current Report Filing (8-k)

European Biotech Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares & Warrants Commencing May 6,...

Statement of Ownership (sc 13g)

EBACU Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

European Biotech Acquisition Corporation (EBACU) News

European Biotech Acquisition Corporation (EBACU)

Professional-Grade Tools, for Individual Investors.

EBACU News

Annual Report (10-k)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Current Report Filing (8-k)

Quarterly Report (10-q)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Quarterly Report (10-q)

Quarterly Report (10-q)

European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report

Current Report Filing (8-k)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Initial Statement of Beneficial Ownership (3)

Current Report Filing (8-k)

European Biotech Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares & Warrants Commencing May 6,...

Statement of Ownership (sc 13g)

EBACU Discussion

Your Recent History